Work

Characterization of Bortezomib Resistant Human Multiple Myeloma Cell Line (HMCL): A Clinically Relevant Model for Novel Drug Development in Multiple Myeloma (MM).

Year: 2006

Type: article

Source: Blood

DOI: 10.1182/blood.v108.11.5050.5050

Authors: Asher Alban Chanan-Khan, Noreen Ersing, Paula Pera, Ralph Bernaki, Lionel Coignet, David W. Goodrich, Raya Haung, Carl W. Porter

Institution: Roswell Park Comprehensive Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2588846758

FWCI:

Cites:

Cited by:

Related to: 10